Trojan Bio
Platform for the generation of bi-functional Trojan antibodies
Operating in nfx portfolio, Trojan Bio was founded in 2021.
Trojan Bio is positioned in nfx portfolio, a segment that rewards a clear, focused offering.
The company is listed at the Pre-Seed stage of development.
| Sector | NFX portfolio |
|---|---|
| Founded | 2021 |
| Stage | Pre-Seed |
Website: www.trojan-bio.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account